Johnson and Johnson
-
Extremities
DePuy Synthes Acquires CrossRoads® Extremity Systems to Further Strengthen Elective Foot & Ankle Portfolio
Innovative Elective Foot & Ankle Products Will Provide Surgeons with Multiple Options to Address Growing Patient Need WEST CHESTER, PA…
Read More » -
Financial
Johnson & Johnson Reports Q3 2021 Results
– Total sales growth of 10.7% to $23.3 Billion with operational growth of 9.9%* and adjusted operational growth of 10.6%*…
Read More » -
Extremities
DePuy Synthes Launches 2.7 mm Variable Angle Locking Compression Plate Clavicle System Designed to Accommodate Different Shapes and Sizes of the Collarbone
New Offering Features Enhanced Plate-to-Bone Fit and Reduced Prominence WEST CHESTER, PA – June 9, 2021 – Today, The Johnson &…
Read More » -
Spine
DePuy Synthes Announces Exclusive Expandable Cage Distribution Agreement with Expanding Innovations Inc.
The X-Pac Expandable Lumbar Cage System Meets Surgeons’ Evolving Needs Within Both the Lumbar Degenerative and Minimally Invasive Spine Segments…
Read More » -
Recon
DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution Designed for Use with the ATTUNE® Total Knee System
PALM BEACH GARDENS, Fla., Jan. 19, 2021 /PRNewswire/ — Today, The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes** has…
Read More » -
COVID-19
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
NEW BRUNSWICK, N.J., July 30, 2020 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) (the Company) today announced that its lead vaccine candidate protected against…
Read More » -
Top Stories
J&J Healthy Workforce Program: Bringing Purpose and Productivity to Life
by Elizabeth Hofheinz, M.P.H., M.Ed. Think of the last time you dragged yourself to the office after a rough night’s…
Read More » -
Financial
Johnson & Johnson Stock Surges 5% After Raising Dividend And Beating Earnings
April 14, 2020 / Sergei Klebnikov, Forbes Staff TOPLINE – Shares of pharmaceutical and consumer goods giant Johnson & Johnson…
Read More » -
Robotics
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
NEW BRUNSWICK, N.J., Dec. 20, 2019 /PRNewswire/ — Dedicated to shaping the next frontier of surgery, Johnson & Johnsoni (NYSE: JNJ) today announced an agreement…
Read More » -
Recon
DePuy Synthes Expands ATTUNE Knee Platform with Cementless Option
WARSAW, Ind., Sept. 9, 2019 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* announced today that DePuy Synthes** is launching the ATTUNE Cementless…
Read More » -
Financial
Johnson & Johnson ordered to pay $572M over opioid crisis
SUSANNAH LUTHI / August 26, 2019 An Oklahoma state judge on Monday ruled that Johnson & Johnson fed the state’s…
Read More » -
Financial
Johnson & Johnson facility DePuy Synthes to create 30 jobs as part of €36m investment
Louise Kelly / January 28 2019 Med tech firm DePuy Synthes is to create 30 jobs at its Irish hub as…
Read More »